H

Hyphens Pharma International Ltd
SGX:1J5

Watchlist Manager
Hyphens Pharma International Ltd
SGX:1J5
Watchlist
Price: 0.285 SGD Market Closed
Market Cap: 88.1m SGD

Hyphens Pharma International Ltd
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hyphens Pharma International Ltd
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
H
Hyphens Pharma International Ltd
SGX:1J5
Total Other Income
-S$1.7m
CAGR 3-Years
-36%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
WAVE Life Sciences Ltd
NASDAQ:WVE
Total Other Income
$3.2m
CAGR 3-Years
-11%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Haw Par Corporation Ltd
SGX:H02
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
IX Biopharma Ltd
SGX:42C
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Hyphens Pharma International Ltd
Glance View

Market Cap
88m SGD
Industry
Pharmaceuticals

Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. The firm's principal activities are those of an investment holding company and provision of management services. The firm's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.

1J5 Intrinsic Value
0.46 SGD
Undervaluation 38%
Intrinsic Value
Price
H

See Also

What is Hyphens Pharma International Ltd's Total Other Income?
Total Other Income
-1.7m SGD

Based on the financial report for Dec 31, 2024, Hyphens Pharma International Ltd's Total Other Income amounts to -1.7m SGD.

What is Hyphens Pharma International Ltd's Total Other Income growth rate?
Total Other Income CAGR 5Y
-29%

Over the last year, the Total Other Income growth was -176%. The average annual Total Other Income growth rates for Hyphens Pharma International Ltd have been -36% over the past three years , -29% over the past five years .

Back to Top